[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab
, , , , , , , , , , and
Jul 29, 2020
About this article
Article Category: Research Article
Published Online: Jul 29, 2020
Page range: 285 - 294
Received: Apr 30, 2020
Accepted: Jun 05, 2020
DOI: https://doi.org/10.2478/raon-2020-0042
Keywords
© 2020 Damijan Valentinuzzi, Martina Vrankar, Nina Boc, Valentina Ahac, Ziga Zupancic, Mojca Unk, Katja Skalic, Ivana Zagar, Andrej Studen, Urban Simoncic, Jens Eickhoff, Robert Jeraj, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Valentinuzzi, Damijan
Jožef Stefan InstituteLjubljana, Slovenia
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Vrankar, Martina
Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Boc, Nina
Institute of Oncology LjubljanaLjubljana, Slovenia
Ahac, Valentina
Institute of Oncology LjubljanaLjubljana, Slovenia
Zupancic, Ziga
Institute of Oncology LjubljanaLjubljana, Slovenia
Unk, Mojca
Institute of Oncology LjubljanaLjubljana, Slovenia
Skalic, Katja
Institute of Oncology LjubljanaLjubljana, Slovenia
Zagar, Ivana
Institute of Oncology LjubljanaLjubljana, Slovenia
Studen, Andrej
Jožef Stefan InstituteLjubljana, Slovenia
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Simoncic, Urban
Jožef Stefan InstituteLjubljana, Slovenia
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Eickhoff, Jens
Department of Biostatistics and Medical Informatics, University of WisconsinMadison, USA
Jeraj, Robert
Jožef Stefan InstituteLjubljana, Slovenia
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Department of Medical Physics, University of WisconsinMadison, USA